Daryl Swain shared C.C.S.V.I. - I.V.C.C.'s note: SOME POPULAR MS MEDICATIONS AND THEIR CANADIAN PATENT INFORMATION.12 mins ·C.C.S.V.I. - I.V.C.C.SOME POPULAR MS MEDICATIONS AND THEIR CANADIAN PATENT INFORMATIONDespite the fact that many MS medications have shown not to prevent progression in Multiple Sclerosis, they continue to be prescribed regularly. The large pharmaceutical industry has capitalized on the sales of their medications, and are protected by patents that bind our Canadian government contractually to guarantee that no generic forms of these medications become available. Why would our government and insurance companies continue to pay billions for medications that have shown in study after study not to do what they were promised to do? ************* IMPORTANT NOTE: - When you click on the Canadian government pages below, you may get a message stating that you were logged out of the page. Leave the page, and go back in and click on it a 2nd time, and it should work.************** ..................................... Copaxone http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02245619&patentNumber_numeroBrevet=2191088&lang=eng&formId=3448 Medicinal ingredient(s): glatiramer acetate Brand Name: COPAXONEDrug Identification Number (DIN): 02245619Route(s) of Administration: Subcutaneous Strength per Unit: 20 mg / 1ml Dosage Form: Solution Patent Number: 2191088Date Granted: 2004-09-28Expiry Date: 2015-05-23 -------------------------- Avonnex http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02269201&patentNumber_numeroBrevet=1341604&lang=eng&formId=5660 Medicinal ingredient(s): interferon beta-1a Brand Name: AVONEX PSDrug Identification Number (DIN): 02269201Route(s) of Administration: Intramuscular Injection Strength per Unit: 30 mcg / 0.5mL Dosage Form: Injection Patent Number: 1341604Date Granted: 2010-05-04Expiry Date: 2027-05-04Filing Date: 1981-04-04 --------------------------- Alemtuzumab http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02290960&patentNumber_numeroBrevet=1339198&lang=eng&formId=4612 Medicinal ingredient(s): alemtuzumab Brand Name: MABCAMPATHDrug Identification Number (DIN): 02290960Route(s) of Administration: Intravenous Strength per Unit: 30mg / ml Dosage Form: Solution Patent Number: 1339198Date Granted: 1997-08-05 Expiry Date: 2014-08-05 ----------------------- Beteserson http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02169649&patentNumber_numeroBrevet=1339707&lang=eng&formId=4487 Medicinal ingredient(s): interferon beta-1b Brand Name: BETASERONDrug Identification Number (DIN): 02169649Route(s) of Administration: Subcutanous injection Strength per Unit: 0.3mg per vial (250 ug / mL when reconstituted) Dosage Form: Lyophilized powder with accompanying diluent Patent Number: 1339707Date Granted: 1998-03-10 Expiry Date: 2015-03-10 ----------------------- Extavia http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02337819&patentNumber_numeroBrevet=1339707&lang=eng&formId=5508 Medicinal ingredient(s): interferon beta-1b Brand Name: EXTAVIADrug Identification Number (DIN): 02337819Route(s) of Administration: Subcutaneous Strength per Unit: 0.3 mg / vial Dosage Form: Powder for Solution Patent Number: 1339707Date Granted: 1998-03-10Expiry Date: 2015-03-10 --------------------------- Aubagio (Teriflunomide) http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02416328&patentNumber_numeroBrevet=2443285&lang=eng&formId=8285 Medicinal ingredient(s): teriflunomide Brand Name: AUBAGIODrug Identification Number (DIN): 02416328Route(s) of Administration: ORAL Strength per Unit: 14 mg Dosage Form: TABLET Number: 2443285Date Granted: 2007-08-21Expiry Date: 2022-04-04 --------------------------- Gilenya (Fingolimod) http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02365480&patentNumber_numeroBrevet=2521325&lang=eng&formId=6042 Medicinal ingredient(s): fingolimod Brand Name: GILENYADrug Identification Number (DIN): 02365480Route(s) of Administration: Oral Strength per Unit: 0.5 mg Dosage Form: Capsules Patent Number: 2521325Date Granted: 2010-09-14Expiry Date: 2024-04-06 --------------------------- Tecfidera (Dimethyl fumerate) BG-12 http://pr-rdb.hc-sc.gc.ca/pr-rdb/patent_result-resultat_brevet.do?action=search_recherche&din=02404508&patentNumber_numeroBrevet=2346438&lang=eng&formId=8058 Medicinal ingredient(s): dimethyl fumarate Brand Name: TECFIDERADrug Identification Number (DIN): 02404508Route(s) of Administration: Oral Strength per Unit: 120 mg Dosage Form: Delayed Release Capsules Patent Number: 2346438Date Granted: 2006-10-03 Expiry Date: 2019-10-29 ----------------------- UPDATED - MARCH 3, 2014